| Product Code: ETC6751956 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of quinolones to China saw a significant increase in concentration in 2024, with top exporting countries being Italy, Ireland, India, Belgium, and the UK. This shift towards high concentration indicates a potential market consolidation. The compound annual growth rate (CAGR) from 2020 to 2024 was a healthy 6.79%, with a notable growth rate of 6.35% from 2023 to 2024. This suggests a continued upward trajectory for quinolones imports in the Chinese market, with key players likely to further solidify their positions in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Quinolones Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Quinolones Market Revenues & Volume, 2021 & 2031F |
3.3 China Quinolones Market - Industry Life Cycle |
3.4 China Quinolones Market - Porter's Five Forces |
3.5 China Quinolones Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 China Quinolones Market Revenues & Volume Share, By Pathogen Type, 2021 & 2031F |
3.7 China Quinolones Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.8 China Quinolones Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 China Quinolones Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 China Quinolones Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Quinolones Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in China |
4.2.2 Growing geriatric population requiring antibiotics |
4.2.3 Rising awareness and adoption of quinolones for various infections |
4.3 Market Restraints |
4.3.1 Stringent regulatory processes for drug approvals in China |
4.3.2 Rising concerns about antibiotic resistance |
4.3.3 Competition from alternative antibiotic classes |
5 China Quinolones Market Trends |
6 China Quinolones Market, By Types |
6.1 China Quinolones Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 China Quinolones Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 China Quinolones Market Revenues & Volume, By Urinary Tract Infection, 2021- 2031F |
6.1.4 China Quinolones Market Revenues & Volume, By Intra-Abdominal Infections, 2021- 2031F |
6.1.5 China Quinolones Market Revenues & Volume, By Blood Stream Infections, 2021- 2031F |
6.1.6 China Quinolones Market Revenues & Volume, By Clostridium Difficile Infections, 2021- 2031F |
6.2 China Quinolones Market, By Pathogen Type |
6.2.1 Overview and Analysis |
6.2.2 China Quinolones Market Revenues & Volume, By Gram-Positive Pathogen, 2021- 2031F |
6.2.3 China Quinolones Market Revenues & Volume, By Gram-Negative Pathogen, 2021- 2031F |
6.3 China Quinolones Market, By Drugs |
6.3.1 Overview and Analysis |
6.3.2 China Quinolones Market Revenues & Volume, By Lomefloxacin, 2021- 2031F |
6.3.3 China Quinolones Market Revenues & Volume, By Gatifloxacin, 2021- 2031F |
6.3.4 China Quinolones Market Revenues & Volume, By Norfloxacin, 2021- 2031F |
6.3.5 China Quinolones Market Revenues & Volume, By Moxifloxacin, 2021- 2031F |
6.3.6 China Quinolones Market Revenues & Volume, By Ciprofloxacin, 2021- 2031F |
6.4 China Quinolones Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 China Quinolones Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 China Quinolones Market Revenues & Volume, By Injectable, 2021- 2031F |
6.5 China Quinolones Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 China Quinolones Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 China Quinolones Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 China Quinolones Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.6 China Quinolones Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 China Quinolones Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 China Quinolones Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 China Quinolones Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 China Quinolones Market Import-Export Trade Statistics |
7.1 China Quinolones Market Export to Major Countries |
7.2 China Quinolones Market Imports from Major Countries |
8 China Quinolones Market Key Performance Indicators |
8.1 Percentage increase in prescriptions of quinolones by healthcare providers |
8.2 Number of clinical trials conducted on new formulations of quinolones |
8.3 Average length of hospital stay for patients treated with quinolones |
8.4 Rate of adverse events reported related to quinolone usage |
8.5 Number of new entrants in the quinolones market in China |
9 China Quinolones Market - Opportunity Assessment |
9.1 China Quinolones Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 China Quinolones Market Opportunity Assessment, By Pathogen Type, 2021 & 2031F |
9.3 China Quinolones Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.4 China Quinolones Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 China Quinolones Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 China Quinolones Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Quinolones Market - Competitive Landscape |
10.1 China Quinolones Market Revenue Share, By Companies, 2024 |
10.2 China Quinolones Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |